SLC7A11 and brain neoplasm: The central hypothesis of this study was that p53 may act as a transcriptional regulator of SLC7A11, whereby the loss or mutation of p53 in brain tumors should show reduced SLC7A11 expression as well as reduced cystine–glutamate transport activity.